ARCHIVES

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

Patients “Raise A Voice” For Provenge Approval.

April 27, 2007

Cancer Letter Editor Finalist for Loeb Award

May 16, 2003

In Brief: Appropriations Bill Hung Up In Senate; Paul Black To Head B.U. Humphrey Center

September 21, 1979

In Brief: NCI, EPA Award contract For Farmers study To Iowa, North Carolina; NIAID’s Hoth to Resign

January 29, 1993

South African Investigator Bezwoda Admits Falsifying Data In High-Dose Chemo Study.

February 11, 2000

NCI Seeks CRADA Partners To Develop Targets Drugs

October 24, 1997